A 25-year-old female presented with a 3-hour history of rapidly decreasing distance visual acuity in both eyes and nausea. Previous examination revealed no ocular abnormality and hypermetropia of 0.75 diopters. Past medical history was positive for morbid obesity and obstructive sleep apnea. The body-mass index (BMI) measured 55.07kg/m 2 . She had recently been started on a combination weight-loss drug, phentermine hydrocholoride 3.75 mg/topiramate 23 mg extended-release daily 11 days prior to presentation. Ocular examination revealed mild ciliary congestion and bilateral shallow anterior chamber. Gonioscopy revealed closed angles in both eyes (grade 0 by Shaffer's classification in all circumferences). Visual acuity was decreased in both eyes and measured 20/125 (6/36) in the right (OD) and 20/200 (6/60) in the left eye (OS) with pin-hole correction. The intraocular pressure (IOP) (Goldmann applanation tonometry) was elevated in both eyes and measured 42mm Hg in the OD This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. 
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None of the three phase III clinical trials-EQUATE, [3] EQUIP, [4] and the CONQUER [5] -have reported any ocular adverse events with fixed-dose combination of phentermine and topiramate. Careful clinical evaluation and multimodal imaging enabled accurate diagnosis and documentation of the ciliochoroidal effusion in this case.
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